AwardedSpainGoods
Suministro del principio activo denominado "CABOZANTINIB 60 MG ORAL " para el Hospital Universitario de Gran Canaria Dr. Negrín
- Published
- Published 18 June 2026
Overview
Supply of Cabozantinib 60 mg oral active pharmaceutical ingredient for Hospital Universitario de Gran Canaria Dr. Negrín, a classified pharmaceutical good (CPV 33690000). The contract was awarded to IPSEN PHARMA, S.A.U on 13 May 2026 for €22,402.56.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 18 June 2026
Various medicinal products
Award outcome
- Awarded value
- €22,403
- Award date
- 13 May 2026
- IPSEN PHARMA, S.A.U
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
18 June 2026
Contracting authority
Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Procuring entityLas Palmas de Gran Canaria, Spain
ID_PLATAFORMA: 21050930148853
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.